MedPath

Eurythmic

Brand Name: Eurythmic

Generic Name: Amiodarone Hydrochloride

Active
Registration Number

DR-XY48173

Dosage Form

Concentrate Solution for Injection/Infusion (IV)

Issuance Date

August 10, 2022

Expiry Date

July 7, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mg/mL (150 mg/3 mL)
PackagingAmber USP Type I glass ampoule with red OPC x 3 mL (Box of 5's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Anti-arrhythmic Agent
A
Application
Initial (Correction)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Amiodarone HydrochlorideActive
Monograph: Amiodarone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform